The induction of cell death by phosphine silver(I) thiocyanate complexes in SNO-esophageal cancer cells
- 30 December 2014
- journal article
- Published by Springer Nature in BioMetals
- Vol. 28 (1) , 219-228
Abstract
Esophageal cancer is one of the least studied cancers and is found to be prominent in black South African males. It is mainly diagnosed in the late stages, and patients tend to have a low 5-year survival rate of only 10 %. Silver is generally used as an antimicrobial agent, with limited reports on anticancer studies. In this study, dimeric silver(I) thiocyanate complexes were used containing a variation of 4-substitued triphenylphosphines, including [AgSCN(PPh3)2]2 (1), [AgSCN{P(4-MeC6H4)3}2]2 (2), [AgSCN{P(4-FC6H4)3}2]2 (3) and [AgSCN{P(4-ClC6H4)3}2]2 (4). All four complexes, with their respective phosphine ligands, PPh3 (L1), P(4-MeC6H4)3 (L2), P(4-FC6H4)3 (L3) and P(4-ClC6H4)3 (L4), were subjected to in vitro toxicity studies in SNO-esophageal cancer cells, using an alamarBlue® assay. Morphological changes, including blebbing and apoptotic body formation, were observed. Phosphatidylserine externalization, a marker of apoptosis, was quantified by flow cytometry. The phosphine ligands L1–L4, on their own, had minimal effect on the malignant while complexes 1–4 resulted in significant cell death. A 10× decreased concentration of these complexes had similar effects than cisplatin, used as the positive control. These complexes show promise as anticancer agents.Keywords
This publication has 33 references indexed in Scilit:
- A novel silver iodide metalo-drug: Experimental and computational modelling assessment of its interaction with intracellular DNA, lipoxygenase and glutathioneEuropean Journal of Medicinal Chemistry, 2014
- Bench-to-bedside review: Mitochondrial injury, oxidative stress and apoptosis – there is nothing more practical than a good theoryCritical Care, 2008
- Apoptosis: A Review of Programmed Cell DeathToxicologic Pathology, 2007
- Mitochondria are primary targets in apoptosis induced by the mixed phosphine gold species chlorotriphenylphosphine-1,3-bis(diphenylphosphino)propanegold(I) in melanoma cell linesBiochemical Pharmacology, 2007
- Chemotherapy and the war on cancerNature Reviews Cancer, 2005
- Changing patterns in the incidence of esophageal and gastric carcinoma in the United StatesCancer, 1998
- Apoptosis, cancer and cancer therapySurgical Oncology, 1997
- An Antimitochondrial Silver ComplexMetal-Based Drugs, 1995
- Silver Diphosphine Complexes as Antimitochondrial AgentsMetal-Based Drugs, 1994
- Phosphines and metal phosphine complexes: Relationship of chemistry to anticancer and other biological activity1988